共 24 条
- [2] Drug Retention Rates Of Biologic Monotherapies For Patients With Rheumatoid Arthritis In Daily Clinical Practice; Using Multicenter Registry In Japan [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S614 - S615
- [9] Use Of Rituximab As Second Line Biologic Agent Compared With Adalimumab, Etanercept and Infliximab In Patients With Rheumatoid Arthritis. A Report From The Rhumadata® Clinical Database and Registry [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S187 - S187